Page last updated: 2024-10-27

flecainide and Eulenburg Disease

flecainide has been researched along with Eulenburg Disease in 1 studies

Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Terracciano, C1
Farina, O1
Esposito, T1
Lombardi, L1
Napolitano, F1
Blasiis, P1
Ciccone, G1
Todisco, V1
Tuccillo, F1
Bernardini, S1
Di Iorio, G1
Melone, MAB1
Sampaolo, S1

Other Studies

1 other study available for flecainide and Eulenburg Disease

ArticleYear
Successful long-term therapy with flecainide in a family with paramyotonia congenita.
    Journal of neurology, neurosurgery, and psychiatry, 2018, Volume: 89, Issue:11

    Topics: Adolescent; Adult; Electromyography; Female; Flecainide; Humans; Male; Middle Aged; Muscle, Skeletal

2018